Literature DB >> 8785425

A rapid assay for measuring the metabolism of [3H]-retinoic acid in cell cultures.

T A Garrabrant1, D W End.   

Abstract

A simple method was developed to detect the metabolism of [3H]-retinoic acid to polar products using intact tumor cells in culture. Unaltered [3H]-retinoic acid was separated from more polar metabolites using C18-bonded solid phase extraction cartridges. Separation of unaltered retinoic acid and polar metabolites was confirmed by HPLC. The murine mammary carcinoma cell line TA3 Ha used in these studies converted 40% to 50% of added radioactive retinoic acid to polar metabolites released into the culture medium during a 4-hr incubation period. Metabolism of [3H]-retinoic acid by TA3 Ha cells was inhibited by the cytochrome P-450 inhibitors ketoconazole, clotrimazole, and liarozole. The simplicity and rapidity of this assay should make it useful for evaluating compounds as inhibitors of retinoic acid metabolism.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8785425     DOI: 10.1016/1056-8719(95)00098-4

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  3 in total

1.  Liver-specific cytochrome P450 CYP2C22 is a direct target of retinoic acid and a retinoic acid-metabolizing enzyme in rat liver.

Authors:  Linxi Qian; Reza Zolfaghari; A Catharine Ross
Journal:  J Lipid Res       Date:  2010-02-10       Impact factor: 5.922

2.  Induction of the oxidative catabolism of retinoid acid in MCF-7 cells.

Authors:  M D Krekels; A Verhoeven; J van Dun; W Cools; C Van Hove; L Dillen; M C Coene; W Wouters
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity.

Authors:  J Van Heusden; R Van Ginckel; H Bruwiere; P Moelans; B Janssen; W Floren; B J van der Leede; J van Dun; G Sanz; M Venet; L Dillen; C Van Hove; G Willemsens; M Janicot; W Wouters
Journal:  Br J Cancer       Date:  2002-02-12       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.